Cited by 4,291Chronic Myeloid Leukemia TreatmentsGenomic variations and chromosomal abnormalitiesAcute Myeloid Leukemia Research

The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

ROWLEY, JANET D.·1973·Nature

DOI 10.1038/243290a0

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1038/243290a0

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

New Technique for Distinguishing between Human Chromosomes
Sumner, A. T., Evans, H. J., & Buckland, R. A. (1971) · Nature New Biology · doi:10.1038/newbio232031a0 · Cited by 1,166
Technique for Identifying Y Chromosomes in Human Interphase Nuclei
Pearson, P. L., Bobrow, M., & Vosa, C. G. (1970) · Nature · doi:10.1038/226078a0 · Cited by 455
DNA Contents of Chromosome Ph 1 and Chromosome 21 in Human Chronic Granulocytic Leukemia
Rudkin, G. T., Hungerford, D. A., & Nowell̀, P. C. (1964) · Science · doi:10.1126/science.144.3623.1229 · Cited by 199
Clinical Implications of Cytogenetic Variants in Chronic Myelocytic Leukemia (CML)
Whang‐Peng, J., Canellos, G. P., Carbone, P. P., & TJIO, J. H. (1968) · Blood · doi:10.1182/blood.v32.5.755.755 · Cited by 179
Philadelphia-Chromosome-Positive and -Negative Chronic Myelocytic Leukemia
Ezdinli, E. Z., SOKAL, J. E., CROSSWHITE, L., & SANDBERG, A. A. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-2-175 · Cited by 177
Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis
Caspersson, T. O., Gahrton, G., Lindsten, J., & Zech, L. (1970) · Experimental Cell Research · doi:10.1016/0014-4827(70)90362-9 · Cited by 172
Chromosome Studies in Preleukemia
Rowley, J. D., Blaisdell, R. K., Jacobson, L., Mikuta, J. C., Byrne, R., & Shepley, L. A. (1966) · Blood · doi:10.1182/blood.v27.6.782.782 · Cited by 132
Self-citation
Distinguishing between the Chromosomes involved in Down's Syndrome (Trisomy 21) and Chronic Myeloid Leukaemia (Ph1) by Fluorescence
O'Riordan, M. L., Robinson, J. A., BUCKTON, K. E., & Evans, H. J. (1971) · Nature · doi:10.1038/230167a0 · Cited by 129
Identification by fluorescence of the G chromosome lost in human meningomas
Mark, J., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1972.tb01017.x · Cited by 115
IDENTIFICATION OF ISOCHROMOSOME 17 IN MYELOID LEUKÆMIA
Lobb, D., Reeves, B. R., & Lawler, S. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90836-7 · Cited by 48

Flagged first, then by citations

Show all 14 references

1 of the 14 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

Chicago Conference. Standardization in human cytogenetics. The National Foundation—March of Dimes (1966).
Paris Conference. Standardization in human cytogenetics. The National Foundation—March of Dimes (1972).
Rowley, J. D., Potter, D., and Mikuta, J., Stain Tech., 46, 97 (1971).
Rowley, J. D., Ann. Génét. (in the press).
Manolov, G., and Manolova, Y., Hereditas, 69, 300 (1971).

Sorted by citations

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
O’Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T. H., Hochhaus, A., Hughes, T. P., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,550
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O’Brien, S. G., Gathmann, I., Kantarjian, H. M., Gattermann, N., Deininger, M. W., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,516
The cancer genome
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
Lozzio, C., & Lozzio, B. (1975) · Blood · doi:10.1182/blood.v45.3.321.bloodjournal453321 · Cited by 2,978
Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome
Daley, G. Q., Etten, R. A. V., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 2,141
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C. L., Hochhaus, A., Guilhot, F., Schiffer, C. A., Gambacorti-Passerini, C. B., Niederwieser, D. W., Resta, D. J., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,005
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
Dalla‐Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,764
The molecular biology of chronic myeloid leukemia
Deininger, M. W., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,654
Chronic Myeloid Leukemia
Sawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,615
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,583
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
Groffen, J., Stephenson, J. R., Heisterkamp, N., DeKlein, A., Bartram, C., & Grosveld, G. C. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,578
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
The impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
Capdeville, R., Buchdunger, E., Zimmermann, J., & Matter, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd839 · Cited by 1,409
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1982) · Nature · doi:10.1038/300765a0 · Cited by 1,378
The Biology of Chronic Myeloid Leukemia
Faderl, S. H., Talpaz, M., Estrov, Z. E., O'Brien, S. M., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,322
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
Deininger, M. W., Buchdunger, E., & Druker, B. J. (2004) · Blood · doi:10.1182/blood-2004-08-3097 · Cited by 1,269
Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
Cleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,212
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,198
Clonal hematopoiesis in human aging and disease
Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156
“Blood cancers such as chronic myeloid leukemia were first demonstrated to be clonal from karyotypic analysis and are the prototypical example of clonal hematopoiesis (18).”
Background
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
Sawyers, C. L. (2002) · Blood · doi:10.1182/blood.v99.10.3530 · Cited by 1,144
Two genetic hits (more or less) to cancer
Knudson, A. G. (2001) · Nature reviews. Cancer · doi:10.1038/35101031 · Cited by 1,122
The Chromosomal Basis of Human Neoplasia
Yunis, J. J. (1983) · Science · doi:10.1126/science.6336310 · Cited by 1,079
Acute lymphoblastic leukaemia
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study
Talpaz, M. (2002) · Blood · doi:10.1182/blood.v99.6.1928 · Cited by 1,011
Stem cell concepts renew cancer research
Dick, J. E. (2008) · Blood · doi:10.1182/blood-2008-08-077941 · Cited by 1,057
Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment
Goldman, J. M., & Melo, J. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020777 · Cited by 961
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.021 · Cited by 886
Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
Druker, B. J., & Lydon, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 707
Structural organization of the bcr gene and its role in the Ph′ translocation
Heisterkamp, N., Stam, K., Groffen, J., de Klein, A., & Grosveld, G. C. (1985) · Nature · doi:10.1038/315758a0 · Cited by 874
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
Konopka, J. B., Watanabe, S. M., & Witte, O. N. (1984) · Cell · doi:10.1016/0092-8674(84)90438-0 · Cited by 872
Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage
Fialkow, P. J., Jacobson, R. J., & Papayannopoulou, T. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90124-3 · Cited by 851
Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomas
Zech, L., Haglund, U., Nilsson, K., & Klein, G. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170108 · Cited by 848
Imatinib Mesylate — A New Oral Targeted Therapy
Savage, D. G., & Antman, K. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmra013339 · Cited by 849
The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias
Epstein, F. H., Kurzrock, R., Gutterman, J. U., & Talpaz, M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191506 · Cited by 833
Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia
Heisterkamp, N., Stephenson, J. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. R., & Grosveld, G. C. (1983) · Nature · doi:10.1038/306239a0 · Cited by 833
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Kim, D., & Salzberg, S. L. (2011) · Genome biology · doi:10.1186/gb-2011-12-8-r72 · Cited by 816
The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
Ben‐Neriah, Y., Daley, G. Q., Mes‐Masson, A., Witte, O. N., & Baltimore, D. (1986) · Science · doi:10.1126/science.3460176 · Cited by 797
PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid Carcinoma
Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C., Mueller, E., Spiegelman, B. M., & Fletcher, J. A. (2000) · Science · doi:10.1126/science.289.5483.1357 · Cited by 780
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance
Mahon, F. X., Deininger, M. W. N., Schultheis, B., Chabrol, J., Reiffers, J., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.3.1070 · Cited by 584
Apoptosis and cancer: the genesis of a research field
Cotter, T. G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2663 · Cited by 783
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Sundaram, S. K., Khazanov, N. A., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 759
The colorectal adenoma–carcinoma sequence
Leslie, A., CAREY, F. A., Pratt, N. R., & Steele, R. J. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02120.x · Cited by 771
Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia
Bartram, C. R., de Klein, A., Hagemeijer, A., van Agthoven, T., van Kessel, A. G., Bootsma, D., Grosveld, G. C., Ferguson-Smith, M. A., Davies, T., Stone, M., et al. (1983) · Nature · doi:10.1038/306277a0 · Cited by 738
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
Kawasaki, E. S., Clark, S., Coyne, M. Y., Smith, S. D., Champlin, R. E., Witte, O. N., & McCormick, F. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5698 · Cited by 701
The emerging complexity of gene fusions in cancer
Mertens, F., Johansson, B., Fioretos, T., & Mitelman, F. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3947 · Cited by 693
The secret ally: immunostimulation by anticancer drugs
Galluzzi, L., Senovilla, L., Zitvogel, L., & Kroemer, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3626 · Cited by 708
Translation of the Philadelphia chromosome into therapy for CML
Druker, B. J. (2008) · Blood · doi:10.1182/blood-2008-07-077958 · Cited by 674
Recurrent gene fusions in prostate cancer
Kumar‐Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2402 · Cited by 663
Acute leukaemia in bcr/abl transgenic mice
Heisterkamp, N., Jenster, G. W., ten Hoeve, J., Zovich, D., Pattengale, P. K., & Groffen, J. (1990) · Nature · doi:10.1038/344251a0 · Cited by 660
Clonal origin of human tumors
Fialkow, P. J. (1976) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(76)90003-2 · Cited by 649
The origin of human cancers
Cairns, J. (1981) · Nature · doi:10.1038/289353a0 · Cited by 644
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
Copland, M., Hamilton, A., Elrick, L. J., Baird, J. W., Allan, E. K., Jordanides, N., Barow, M., Mountford, J. C., & Holyoake, T. L. (2006) · Blood · doi:10.1182/blood-2005-07-2947 · Cited by 635
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Melo, J. V., & Barnes, D. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2147 · Cited by 629
The biology of CML blast crisis
Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 608
Chromosome Aberrations and Cancer
Solomon, E., Borrow, J., & Goddard, A. D. (1991) · Science · doi:10.1126/science.1957167 · Cited by 580
ErbB receptors: from oncogenes to targeted cancer therapies
Zhang, H., Berezov, A., Wang, Q., Zhang, G., Drebin, J. A., Murali, R., & Greene, M. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32278 · Cited by 594
Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.
Daley, G. Q., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9312 · Cited by 563
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
Bhatia, R., Holtz, M. S., Niu, N., Gray, R., Snyder, D., Sawyers, C. L., Arber, D. A., Slovak, M. L., & Forman, S. J. (2003) · Blood · doi:10.1182/blood-2002-09-2780 · Cited by 552
PML targeting eradicates quiescent leukaemia-initiating cells
Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G. N., Ikeda, Y., Rosenblatt, J. M., Avigan, D., Teruya‐Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07016 · Cited by 538
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Kuntz, E. M., Baquero, P., Michie, A. M., Dunn, K. M., Tardito, S., Holyoake, T. L., Helgason, G. V., & Gottlieb, E. (2017) · Nature Medicine · doi:10.1038/nm.4399 · Cited by 550
A historical overview of protein kinases and their targeted small molecule inhibitors
Roskoski, R. J. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.010 · Cited by 547
Smart drugs: Tyrosine kinase inhibitors in cancer therapy
Shawver, L. K., Slamon, D. J., & Ullrich, A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00039-9 · Cited by 532
The discovery of first-in-class drugs: origins and evolution
Eder, J., Sedrani, R., & Wiesmann, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4336 · Cited by 514
Clonal genomic alterations in glioma malignancy stages.
Cd, J., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjöld, M., Collins, V. P., & Cavenee, W. K. (1988) · PubMed · Cited by 512
Isolation of a Highly Quiescent Subpopulation of Primitive Leukemic Cells in Chronic Myeloid Leukemia
Holyoake, T. L., Jiang, X., Eaves, C. J., & Eaves, A. C. (1999) · Blood · doi:10.1182/blood.v94.6.2056 · Cited by 511
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
Bedi, A., Zehnbauer, B., Barber, J. P., Sharkis, S. J., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 506
CTCF and Cohesin in Genome Folding and Transcriptional Gene Regulation
Merkenschlager, M., & Nora, E. P. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022339 · Cited by 528
A continuum model for tumour suppression
Berger, A. H., Knudson, A. G., & Pandolfi, P. P. (2011) · Nature · doi:10.1038/nature10275 · Cited by 521
Clinical pharmacokinetics of tyrosine kinase inhibitors
van Erp, N. P., Gelderblom, H., & Guchelaar, H.-J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.08.004 · Cited by 503
A robustness-based approach to systems-oriented drug design
Kitano, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2195 · Cited by 488
Response and Resistance to BCR-ABL1-Targeted Therapies
Braun, T. P., Eide, C. A., & Druker, B. J. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.006 · Cited by 498
The mutation spectrum revealed by paired genome sequences from a lung cancer patient
Lee, W., Jiang, Z., Liu, J., Haverty, P. M., Guan, Y., Stinson, J., Yue, P., Zhang, Y., Pant, K. P., Bhatt, D., et al. (2010) · Nature · doi:10.1038/nature09004 · Cited by 492
Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals
Biernaux, C., Loos, M., Sels, A., Huez, G., & Stryckmans, P. (1995) · Blood · doi:10.1182/blood.v86.8.3118.3118 · Cited by 485
Imatinib: A Breakthrough of Targeted Therapy in Cancer
Iqbal, N., & Iqbal, N. (2014) · Chemotherapy Research and Practice · doi:10.1155/2014/357027 · Cited by 481
Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso, N., Frank, D. A., & Griffin, J. D. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.811 · Cited by 481
A General Theory of Carcinogenesis
Comings, D. E. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.12.3324 · Cited by 462
The new cytogenetics: blurring the boundaries with molecular biology
Speicher, M. R., & Carter, N. P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1692 · Cited by 475
Chronic Myelogenous Leukemia: Biology and Therapy
Faderl, S. H., Talpaz, M., Estrov, Z. E., & Kantarjian, H. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00008 · Cited by 457
Integrative detection and analysis of structural variation in cancer genomes
Dixon, J. R., Xu, J., Dileep, V., Zhan, Y., Song, F., Le, V. T., Yardımcı, G. G., Chakraborty, A., Bann, D. V., Wang, Y., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0195-8 · Cited by 452
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A., & Canaani, E. (1986) · Cell · doi:10.1016/0092-8674(86)90450-2 · Cited by 452
Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia
Johansson, B., Fioretos, T., & Mitelman, F. (2002) · Acta Haematologica · doi:10.1159/000046636 · Cited by 455
Chronic myelogenous leukemia: a concise update
Kantarjian, H. M., Deisseroth, A. B., Kurzrock, R., Estrov, Z. E., & Talpaz, M. (1993) · Blood · doi:10.1182/blood.v82.3.691.691 · Cited by 443
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
JENNINGS, C. D., & Foon, K. A. (1997) · Blood · doi:10.1182/blood.v90.8.2863 · Cited by 441
Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
Jabbour, E. J., & Kantarjian, H. M. (2020) · American Journal of Hematology · doi:10.1002/ajh.25792 · Cited by 425
Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring
Jabbour, E. J., & Kantarjian, H. M. (2018) · American Journal of Hematology · doi:10.1002/ajh.25011 · Cited by 421
The BCR-ABL Story: Bench to Bedside and Back
Wong, S., & Witte, O. N. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104753 · Cited by 410
Polypeptide Growth Factors: Roles In Normal And Abnormal Cell Growth
Deuel, T. F. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.002303 · Cited by 395
THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS
Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 399
Self-citation
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
Preudhomme, C., Guilhot, J., Nicolini, F. E., Guerci‐Bresler, A., Huguet, F., Maloisel, F., Coiteux, V., Gardembas, M., Berthou, C., Vekhoff, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004095 · Cited by 400
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Jaiswal, S., & Libby, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0247-5 · Cited by 386
Massively Parallel Sequencing: The Next Big Thing in Genetic Medicine
Tucker, T., Marra, M. A., & Friedman, J. M. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.06.022 · Cited by 393
Chronic myeloid leukaemia
Apperley, J. F. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62120-0 · Cited by 398
DNA Microarrays in Clinical Oncology
Ramaswamy, S., & Golub, T. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.7.1932 · Cited by 379
Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia
Hermans, A., Heisterkamp, N., Lindern, M. V., van Baal, S., Meijer, D., van der Plas, D., Wiedemann, L. M., Groffen, J., Bootsma, D., & Grosveld, G. C. (1987) · Cell · doi:10.1016/0092-8674(87)90007-9 · Cited by 378
Imatinib as a Paradigm of Targeted Therapies
Druker, B. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)91001-9 · Cited by 372
Detection of bcr - abl Fusion in Chronic Myelogeneous Leukemia by in Situ Hybridization
Tkachuk, D., Westbrook, C. A., Andreeff, M., Donlon, T. A., Cleary, M. L., Suryanarayan, K., Homge, M., Redner, A., Gray, J. W., & Pinkel, D. (1990) · Science · doi:10.1126/science.2237408 · Cited by 368

Authors: ROWLEY, J. D.
Affiliations: University of Chicago (US)
Corresponding author: ROWLEY, JANET D.
ORCID: ROWLEY, JANET D.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1973-06
Volume: 243
Issue: 5405
Pages: 290-293
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/243290a0
OpenAlex: W1998593414
Cited by: 4,291
References: 14
Citations by year: 2026: 66 · 2025: 83 · 2024: 86 · 2023: 106 · 2022: 121 · 2021: 128 · 2020: 102 · 2019: 105 · 2018: 124 · 2017: 138 · 2016: 131 · 2015: 155 · 2014: 130 · 2013: 148 · 2012: 139
FWCI: 52.60
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords: chronic myeloid leukemia, Philadelphia chromosome, chromosome 22q deletion, chromosome 9q, translocation, quinacrine fluorescence, G-banding, chromosomal abnormalities, cytogenetics
MeSH terms: Adolescent, Adult, Aged, Bone Marrow Cells, Chromosome Aberrations, Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, Fluorescent Dyes, Humans, Karyotyping, Leukemia, Myeloid, Leukocytes, Methods, Middle Aged, Mitosis, Quinacrine, Staining and Labeling, Chromosome Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks